Auteurs Bailly-Maitre B, de Sousa G, Boulukos K, Gugenheim J, Rahmani R
Cell death and differentiation Mar 2001
Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling.Auteurs Gual P, Giordano S, Anguissola S, Parker PJ, Comoglio PM
Oncogene Jan 2001
Cross-talk between the proto-oncogenes Met and Ron.Auteurs Follenzi A, Bakovic S, Gual P, Stella MC, Longati P, Comoglio PM
Oncogene Jun 2000
Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis.Auteurs Gual P, Giordano S, Williams TA, Rocchi S, Van Obberghen E, Comoglio PM
Oncogene Mar 2000
Different point mutations in the met oncogene elicit distinct biological properties.Auteurs Giordano S, Maffe A, Williams TA, Artigiani S, Gual P, Bardelli A, Basilico C, Michieli P, Comoglio PM
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Feb 2000
MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential.Auteurs Williams TA, Longati P, Pugliese L, Gual P, Bardelli A, Michieli P
Journal of cellular physiology Dec 1999
Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor.Auteurs Gual P, Baron V, Lequoy V, Van Obberghen E
Endocrinology Mar 1998
Role of the insulin receptor C-terminal acidic domain in the modulation of the receptor kinase by polybasic effectors.Auteurs Baron V, Gual P, Alengrin F, Van Obberghen E
European journal of biochemistry Oct 1996
Insulin receptor-induced phosphorylation of cellular and synthetic substrates is regulated by the receptor beta-subunit C-terminus.Auteurs Gual P, Baron V, Alengrin F, Mothe I, Van Obberghen E
Endocrinology Aug 1996
A conformational change in the beta-subunit of the insulin-like growth factor I receptor identified by antipeptide antibodies.Auteurs Gual P, Baron V, Alengrin F, Van Obberghen E
Endocrinology Dec 1995